Association between sleep pattern and pharmacological treatment in children with attention deficit disorder with
Nathalia Sena Rocha1, Rogério do Espírito Santo Amorim Correa1, Adria Carolina de Melo Dias1
1Universidade do Estado do Pará, Marabá, PA, Brasil.
Insights
Pharmacological treatments for attention deficit hyperactivity disorder (ADHD) can improve symptoms but may negatively impact children's sleep. Atomoxetine appears to have fewer sleep-related side effects compared to other ADHD medications.
Area of Science:
- Pediatric Neurology
- Sleep Medicine
- Pharmacology
Background:
- Attention deficit hyperactivity disorder (ADHD) is a common neurodevelopmental disorder in children.
- Sleep disturbances are frequently observed in children with ADHD, impacting their daily functioning and treatment outcomes.
Approach:
- A comprehensive literature search was conducted across major scientific databases (Cochrane Library, PubMed, LILACS, Embase, Scopus, CINAHL, Web of Science).
- The search focused on studies evaluating the effects of various pharmacological treatments on the sleep patterns of children diagnosed with ADHD.
Key Points:
- Several ADHD medications, including guanfacine, methylphenidate, dasotraline, L-theanine, and lisdexamfetamine, were found to reduce ADHD symptoms.
- However, all these medications, with the exception of atomoxetine, were associated with adverse effects on sleep quality.
- Observed sleep disturbances included reduced rapid eye movement (REM) and non-REM sleep, decreased slow-wave sleep, and prolonged sleep onset latency.
Conclusions:
- Pharmacological interventions for ADHD can negatively affect sleep quality in pediatric populations.
- Atomoxetine demonstrated a comparatively lower impact on sleep variables among the studied ADHD medications.
Objective:
The aim of this study was to analyze the effect of the pharmacological treatment on the sleep patterns of children with attention deficit hyperactivity disorder (ADHD).
Data Source:
A high-sensitivity electronic search was performed in the following databases: Cochrane Library, MEDLINE via PubMed, LILACS via the Regional Health Portal (BVS), Embase, Scopus, CINAHL, and Web of Science, as recommended by the Cochrane Handbook, and which has undergone peer review according to the PRESS Guide.
Data Synthesis:
The studies contemplated the use of the drugs atomoxetine, guanfacine, methylphenidate, dasotraline, L-theanine, and lisdexamfetamine. They showed efficiency in reducing the symptoms of ADHD, although all, except atomoxetine, affected sleep quality, such as by reducing total rapid eye movement (REM), non-REM phase, slow-wave sleep time, and longer sleep-onset latency.
Conclusions:
The drugs used in the treatment of ADHD seem to have negative repercussions on the sleep quality of children, with the drug atomoxetine showing lesser effects on this variable.
More Related Videos
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
04:33Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Management of Insomnia
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Drug Therapy
Antianxiety Medications
